A San Francisco federal judge has rejected a motion asking him to throw out a favorable verdict for the University of California in a huge patent dispute and start a retrial from scratch.

U.S. District Judge Charles Legge refused Genentech Inc.’s request to overturn jurors’ June verdict that UC’s 1982 patent for human growth hormone was “enabled” or, in other words, adequate for use by other scientists.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]